Published in ScientificWorldJournal on August 02, 2012
Drug abuse: hedonic homeostatic dysregulation. Science (1997) 8.22
Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci (2005) 5.97
Is there a common molecular pathway for addiction? Nat Neurosci (2005) 5.43
Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains. J Neurosci (2002) 5.14
Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci (1999) 5.02
Columnar organization in the midbrain periaqueductal gray: modules for emotional expression? Trends Neurosci (1994) 3.75
Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev (2001) 3.45
Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior. Annu Rev Physiol (2010) 3.38
Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci (2005) 3.38
Drug addiction. N Engl J Med (2003) 3.33
Synaptic islands defined by the territory of a single astrocyte. J Neurosci (2007) 3.10
The tripartite synapse: roles for gliotransmission in health and disease. Trends Mol Med (2007) 3.05
What turns CREB on? Cell Signal (2004) 3.03
Acute p38-mediated modulation of tetrodotoxin-resistant sodium channels in mouse sensory neurons by tumor necrosis factor-alpha. J Neurosci (2006) 2.47
Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci (2007) 2.44
Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward. ScientificWorldJournal (2007) 2.43
Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav Immun (2009) 2.19
A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J Neurosci (2004) 2.14
Regulation of proenkephalin by Fos and Jun. Science (1989) 2.03
The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. J Neurosci (2002) 2.02
Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. Science (1996) 2.01
Molecular neurobiology of addiction. Am J Addict (2001) 1.97
Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Exp Physiol (2005) 1.94
The involvement of glial cells in the development of morphine tolerance. Neurosci Res (2001) 1.87
A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res (1991) 1.84
Morphine activates neuroinflammation in a manner parallel to endotoxin. Proc Natl Acad Sci U S A (2012) 1.80
"Listening" and "talking" to neurons: implications of immune activation for pain control and increasing the efficacy of opioids. Brain Res Rev (2007) 1.62
Attenuation of morphine tolerance, withdrawal-induced hyperalgesia, and associated spinal inflammatory immune responses by propentofylline in rats. Neuropsychopharmacology (2004) 1.61
IL-1ra alleviates inflammatory hyperalgesia through preventing phosphorylation of NMDA receptor NR-1 subunit in rats. Pain (2007) 1.59
Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast). Brain Behav Immun (2008) 1.58
Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone-precipitated morphine withdrawal. J Neurosci (2002) 1.58
Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro. J Physiol (1997) 1.57
Dysregulated postsynaptic density and endocytic zone in the amygdala of human heroin and cocaine abusers. Biol Psychiatry (2010) 1.56
Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. J Neurosci (1998) 1.54
Neural substrates of opiate withdrawal. Trends Neurosci (1992) 1.52
Astrocyte-mediated activation of neuronal kainate receptors. Proc Natl Acad Sci U S A (2004) 1.48
Ibudilast (AV-411). A new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromes. Expert Opin Investig Drugs (2007) 1.45
Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence. Brain Res Brain Res Rev (2001) 1.44
Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice. Glia (2008) 1.44
CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J Neurosci (1997) 1.38
Astrocytic dysfunction: insights on the role in neurodegeneration. Brain Res Bull (2009) 1.34
Cell type-specific interleukin-1beta signaling in the CNS. J Neurosci (2004) 1.33
TNF-α contributes to spinal cord synaptic plasticity and inflammatory pain: distinct role of TNF receptor subtypes 1 and 2. Pain (2010) 1.31
In vivo regulation of extracellular signal-regulated protein kinase (ERK) and protein kinase B (Akt) phosphorylation by acute and chronic morphine. J Pharmacol Exp Ther (2004) 1.30
Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J Pharmacol Exp Ther (1992) 1.29
Knockout of ERK1 enhances cocaine-evoked immediate early gene expression and behavioral plasticity. Neuropsychopharmacology (2006) 1.29
Opposite modulation of opiate withdrawal behaviors on microinfusion of a protein kinase A inhibitor versus activator into the locus coeruleus or periaqueductal gray. J Neurosci (1997) 1.28
Cytokines regulate beta-2-adrenergic receptor responsiveness in airway smooth muscle via multiple PKA- and EP2 receptor-dependent mechanisms. Biochemistry (2005) 1.23
Possible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequences. Neuroscience (2010) 1.22
Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro. Neuropharmacology (2003) 1.22
Spinal glial TLR4-mediated nociception and production of prostaglandin E(2) and TNF. Br J Pharmacol (2010) 1.16
GABA transporter currents activated by protein kinase A excite midbrain neurons during opioid withdrawal. Neuron (2005) 1.15
From mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcotics. Pharmacogenet Genomics (2009) 1.11
Astrocytic control of synaptic transmission and plasticity: a target for drugs of abuse? Neuropharmacology (2008) 1.11
The role of glia in the hypothalamus: implications for gonadal steroid feedback and reproductive neuroendocrine output. Reproduction (2008) 1.11
Genetic analysis of drug addiction: the role of cAMP response element binding protein. J Mol Med (Berl) (1998) 1.10
Implication of activated astrocytes in the development of drug dependence: differences between methamphetamine and morphine. Ann N Y Acad Sci (2008) 1.10
Opioids suppress spontaneous and NMDA-induced inhibitory postsynaptic currents in the dorsal raphe nucleus of the rat in vitro. Brain Res (1997) 1.10
Tumor necrosis factor alpha increases cytosolic calcium responses to AMPA and KCl in primary cultures of rat hippocampal neurons. Brain Res (2003) 1.09
Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity. Neuroscience (2010) 1.07
Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human. Br J Pharmacol (2011) 1.07
The effects of illicit drugs on the HIV infected brain. Front Biosci (2008) 1.04
Glia: they make your memories stick! Trends Neurosci (2007) 1.04
Activation of the spinal ERK signaling pathway contributes naloxone-precipitated withdrawal in morphine-dependent rats. Pain (2005) 0.99
Effect of IL-1 beta on responses of cultured human airway smooth muscle cells to bronchodilator agonists. Am J Respir Cell Mol Biol (1997) 0.98
Local opioid withdrawal in rat single periaqueductal gray neurons in vitro. J Neurosci (1996) 0.98
Regulation of expression of cAMP response element-binding protein in the locus coeruleus in vivo and in a locus coeruleus-like cell line in vitro. Proc Natl Acad Sci U S A (1994) 0.97
Periaqueductal gray matter projections to midline and intralaminar thalamic nuclei of the rat. J Comp Neurol (2000) 0.96
Sites of action of morphine involved in the development of physical dependence in rats. II. Morphine withdrawal precipitated by application of morphine antagonists into restricted parts of the ventricular system and by microinjection into various brain areas. Psychopharmacologia (1976) 0.95
Drug-induced GABA transporter currents enhance GABA release to induce opioid withdrawal behaviors. Nat Neurosci (2011) 0.93
Autonomic areas of rat brain exhibit increased Fos-like immunoreactivity during opiate withdrawal in rats. Brain Res (1993) 0.93
Involvement of glial glutamate transporters in morphine dependence. Ann N Y Acad Sci (2004) 0.93
Physical dependence of opiate-like peptides. Science (1976) 0.92
A neuroactive steroid, dehydroepiandrosterone sulfate, prevents the development of morphine dependence and tolerance via c-fos expression linked to the extracellular signal-regulated protein kinase. Behav Brain Res (2004) 0.92
Protein kinases in the locus coeruleus and periaqueductal gray matter are involved in the expression of opiate withdrawal. Naunyn Schmiedebergs Arch Pharmacol (1995) 0.91
Effects of sublingually given naloxone in opioid-dependent human volunteers. Drug Alcohol Depend (1990) 0.90
TNF-alpha increases the frequency of spontaneous miniature synaptic currents in cultured rat hippocampal neurons. Brain Res (1994) 0.90
The role of TNFα in the periaqueductal gray during naloxone-precipitated morphine withdrawal in rats. Neuropsychopharmacology (2010) 0.87
Physical dependence produced by central morphine infusions: an anatomical mapping study. Neurosci Biobehav Rev (1994) 0.83
Glia. Glee for glia. Introduction. Science (2010) 0.83
Regulation of extracellular signal-regulated kinases (ERKs) by naloxone-induced morphine withdrawal in the brain stress system. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.82
Detoxification of rehabilitated methadone-maintained patients. JAMA (1973) 0.80
Increased fos-like immunoreactivity in the periaqueductal gray of anaesthetised rats during opiate withdrawal. Neurosci Lett (1995) 0.80
Precipitated morphine withdrawal stimulates multiple activator protein-1 signaling pathways in rat brain. Mol Pharmacol (1995) 0.79
Regional Fos expression induced by morphine withdrawal in the 7-day-old rat. Dev Psychobiol (2009) 0.79
Enkephalinergic neurons in the periaqueductal gray and morphine withdrawal. Jpn J Pharmacol (2000) 0.79
Enhanced Fos expression in glutamic acid decarboxylase immunoreactive neurons of the mouse periaqueductal grey during opioid withdrawal. Neuroscience (2005) 0.79
Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval II. J Pharmacol Exp Ther (1990) 0.78
Mu type opioid receptors in rat periaqueductal gray-enriched P2 membrane are coupled to G-protein-mediated inhibition of adenylyl cyclase. FEBS Lett (1989) 0.78
Time course of morphine withdrawal and preproenkephalin gene expression in the periaqueductal gray of rats. Brain Res Mol Brain Res (1998) 0.77
A calbindin immunoreactive "deep pain' recipient thalamic nucleus in the rat. Neuroreport (1996) 0.75
Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg (2014) 2.97
The effects of anesthetic technique on cancer recurrence in percutaneous radiofrequency ablation of small hepatocellular carcinoma. Anesth Analg (2011) 2.11
Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain. Mol Ther (2004) 1.56
Rolapitant for the prevention of postoperative nausea and vomiting: a prospective, double-blinded, placebo-controlled randomized trial. Anesth Analg (2011) 1.51
Spinal antinociceptive action of amiloride and its interaction with tizanidine in the rat formalin test. Pain Res Manag (2015) 1.39
A Phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. Am J Ther (2010) 1.33
Efficacy profile of liposome bupivacaine, a novel formulation of bupivacaine for postsurgical analgesia. J Pain Res (2012) 1.20
Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium: a comparison with spontaneous recovery from succinylcholine. Anesthesiology (2009) 1.16
A calcium-activated chloride channel (HCLCA1) is strongly related to IL-9 expression and mucus production in bronchial epithelium of patients with asthma. J Allergy Clin Immunol (2002) 1.16
Glial TNFα in the spinal cord regulates neuropathic pain induced by HIV gp120 application in rats. Mol Pain (2011) 1.15
Engineering an endomorphin-2 gene for use in neuropathic pain therapy. Pain (2007) 1.13
Transgenic inhibition of glial NF-kappa B reduces pain behavior and inflammation after peripheral nerve injury. Pain (2010) 1.11
The impact of current antiemetic practices on patient outcomes: a prospective study on high-risk patients. Anesth Analg (2008) 1.10
Applications of gene therapy to the treatment of chronic pain. Curr Gene Ther (2008) 1.03
A polymorphism in the human UGRP1 gene promoter that regulates transcription is associated with an increased risk of asthma. Am J Hum Genet (2002) 1.00
Multicenter assessment of the Iowa Satisfaction with Anesthesia Scale, an instrument that measures patient satisfaction with monitored anesthesia care. Anesth Analg (2011) 0.96
Interleukin-9 induces mucous cell metaplasia independent of inflammation. Am J Respir Cell Mol Biol (2003) 0.94
Gene therapy directed at the neuroimmune component of chronic pain with particular attention to the role of TNF alpha. Neurosci Lett (2008) 0.93
A calcium-activated chloride channel blocker inhibits goblet cell metaplasia and mucus overproduction. Novartis Found Symp (2002) 0.92
Involvement of IL-9 in the bronchial phenotype of patients with nasal polyposis. J Allergy Clin Immunol (2004) 0.92
Monitored anesthesia care (MAC) sedation: clinical utility of fospropofol. Ther Clin Risk Manag (2009) 0.91
The pharmacokinetics and pharmacodynamics of liposome bupivacaine administered via a single epidural injection to healthy volunteers. Reg Anesth Pain Med (2012) 0.90
The role of TNFα in the periaqueductal gray during naloxone-precipitated morphine withdrawal in rats. Neuropsychopharmacology (2010) 0.87
Diabetic neuropathic pain development in type 2 diabetic mouse model and the prophylactic and therapeutic effects of coenzyme Q10. Neurobiol Dis (2013) 0.87
Niflumic acid and MSI-2216 reduce TNF-alpha-induced mucin expression in human airway mucosa. J Allergy Clin Immunol (2005) 0.87
Prophylactic and antinociceptive effects of coenzyme Q10 on diabetic neuropathic pain in a mouse model of type 1 diabetes. Anesthesiology (2013) 0.87
CYP2D6 poor metabolizer genotype and smoking predict severe postoperative pain in female patients on arrival to the recovery room. Pain Med (2012) 0.87
Reduction of voltage gated sodium channel protein in DRG by vector mediated miRNA reduces pain in rats with painful diabetic neuropathy. Mol Pain (2012) 0.84
Effect of Th2 type cytokines on hCLCA1 and mucus expression in cystic fibrosis airways. J Cyst Fibros (2010) 0.83
The antinociceptive activity of intrathecally administered amiloride and its interactions with morphine and clonidine in rats. J Pain (2011) 0.83
The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection. Ann Surg Oncol (2012) 0.83
Double-blind comparison of granisetron, promethazine, or a combination of both for the prevention of postoperative nausea and vomiting in females undergoing outpatient laparoscopies. Can J Anaesth (2009) 0.83
LPS-induced mucin expression in human sinus mucosa can be attenuated by hCLCA inhibitors. J Endotoxin Res (2007) 0.82
Increased expression of interleukin-9, interleukin-9 receptor, and the calcium-activated chloride channel hCLCA1 in the upper airways of patients with cystic fibrosis. Laryngoscope (2003) 0.82
Talniflumate increases survival in a cystic fibrosis mouse model of distal intestinal obstructive syndrome. J Pharmacol Exp Ther (2005) 0.82
Pain and genetics. Curr Opin Anaesthesiol (2012) 0.82
Central sprouting of uninjured small fiber afferents in the adult rat spinal cord following spinal nerve ligation. Eur J Neurosci (2004) 0.81
TNFα is involved in neuropathic pain induced by nucleoside reverse transcriptase inhibitor in rats. Brain Behav Immun (2011) 0.80
CYP3A4 * 1G Genetic Polymorphism Influences Metabolism of Fentanyl in Human Liver Microsomes in Chinese Patients. Pharmacology (2015) 0.80
Up-Regulation of Interleukin-9 and the Interleukin-9-Associated Calcium-Activated Chloride Channel hCLCA1 in Nasal Mucosa Following In Vivo Allergen Challenge. Allergy Asthma Clin Immunol (2007) 0.79
Inhibition of Mitochondrial Fission Protein Reduced Mechanical Allodynia and Suppressed Spinal Mitochondrial Superoxide Induced by Perineural Human Immunodeficiency Virus gp120 in Rats. Anesth Analg (2016) 0.79
Gene Transfer of Glutamic Acid Decarboxylase 67 by Herpes Simplex Virus Vectors Suppresses Neuropathic Pain Induced by Human Immunodeficiency Virus gp120 Combined with ddC in Rats. Anesth Analg (2015) 0.79
Sox-9 facilitates differentiation of adipose tissue-derived stem cells into a chondrocyte-like phenotype in vitro. J Orthop Res (2011) 0.79
Increased expression of the calcium-activated chloride channel hCLCA1 in airways of patients with obstructive chronic bronchitis. Can Respir J (2005) 0.79
IL-10 mediated by herpes simplex virus vector reduces neuropathic pain induced by HIV gp120 combined with ddC in rats. Mol Pain (2014) 0.78
Long-term survival after resection of hepatocelluar carcinoma: a potential risk associated with the choice of postoperative analgesia. Anesth Analg (2014) 0.78
TNFα and IL-1β are mediated by both TLR4 and Nod1 pathways in the cultured HAPI cells stimulated by LPS. Biochem Biophys Res Commun (2012) 0.78
Interleukin 10 mediated by herpes simplex virus vectors suppresses neuropathic pain induced by human immunodeficiency virus gp120 in rats. Anesth Analg (2014) 0.78
Does the systolic pressure variation change in the prone position? J Clin Monit Comput (2009) 0.78
Mechanical allodynia induced by nucleoside reverse transcriptase inhibitor is suppressed by p55TNFSR mediated by herpes simplex virus vector through the SDF1α/CXCR4 system in rats. Anesth Analg (2014) 0.77
Glial NF-κB inhibition alters neuropeptide expression after sciatic nerve injury in mice. Brain Res (2011) 0.77
The Association of Dry Eye Symptom Severity and Comorbid Insomnia in US Veterans. Eye Contact Lens (2017) 0.76
Characteristics of Ocular Pain Complaints in Patients With Idiopathic Dry Eye Symptoms. Eye Contact Lens (2016) 0.76
Crosstalk between JNK and NF-κB in the KDO2-mediated production of TNFα in HAPI cells. Cell Mol Neurobiol (2012) 0.75
Evaluation of distal radial artery cross-sectional internal diameter in pediatric patients using ultrasound. Paediatr Anaesth (2013) 0.75
[EXPRESS] Evidence that Dry Eye Represents a Chronic Overlapping Pain Condition. Mol Pain (2017) 0.75
The antinociceptive effect of intrathecal escin in the rat formalin test. Eur J Pharmacol (2011) 0.75
Neuropathic-Like Ocular Pain and Nonocular Comorbidities Correlate With Dry Eye Symptoms. Eye Contact Lens (2017) 0.75
Opioid-induced Hallucinations: A Review of the Literature, Pathophysiology, Diagnosis, and Treatment. Anesth Analg (2016) 0.75
Impact of human CA8 on thermal antinociception in relation to morphine equivalence in mice. Neuroreport (2017) 0.75
Risk factors for anastomotic leakage following anterior resection for colorectal cancer: the effect of epidural analgesia on occurrence. Int J Colorectal Dis (2012) 0.75
Tapentadol extended-release: a recent addition to our analgesic armamentarium. Pain Manag (2012) 0.75
[Clinical value of viral detection of liquid chip method in community-acquired pneumonia]. Zhonghua Yi Xue Za Zhi (2015) 0.75
Intravenous Amisulpride for the Prevention of Postoperative Nausea and Vomiting: Two Concurrent, Randomized, Double-blind, Placebo-controlled Trials. Anesthesiology (2016) 0.75